Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Isozaki, Takeo ^a   Amin, M A ^a   Arbab, Ali S ^b   Koch, Alisa E ^a,c   Ha, Christine M ^a   Edhayan, Gautam ^a   Haines III, G K ^d   Ruth, Jeffrey H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c Veteran's Administration   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL16 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; MATRIGEL; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT HUMAN INHIBITOR OF DNA BINDING 1; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CHEMOKINES, CXC; CXCL16 PROTEIN, HUMAN; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION PROTEIN 1; RECEPTORS, SCAVENGER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL ASSAY; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; CHEMOTAXIS ASSAY; CHIMERA; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SCID MOUSE; SERUM; SYNOVIAL FLUID; SYNOVIUM; TUBE FORMATION ASSAY; ANIMAL MODEL; ENDOTHELIUM CELL; HISTOLOGY; HUMAN CELL; MESENCHYMAL STEM CELL; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR REMODELING; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; METABOLISM; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; REAL-TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CHEMOKINES, CXC; CHEMOTAXIS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, SCAVENGER;

EID: 84899151550     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4507     Document Type: Article

References (40)

1. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003, 62:ii60-ii67. 1766740, 14532152.
2. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000, 50:1-15. 10.1023/A:1006493130855, 11245270.
3. Gonzalez-Amaro R, Sanchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit Rev Immunol 1999, 19:389-429.
4. Godessart N, Kunkel SL. Chemokines in autoimmune disease. Curr Opin Immunol 2001, 13:670-675. 10.1016/S0952-7915(01)00277-1, 11677088.
5. Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum 2009, 60:3168-3179. 10.1002/art.24921, 19877034.
6. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998, 101:746-754. 10.1172/JCI1422, 508621, 9466968.
7. Isner JM, Kalka C, Kawamoto A, Asahara T. Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair. Ann N Y Acad Sci 2001, 953:75-84.
8. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA, Benezra R, Mittal V. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007, 21:1546-1558. 10.1101/gad.436307, 1891431, 17575055.
9. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198. 10.1126/science.1150224, 18187653.
10. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006, 6:835-845. 10.1038/nrc1971, 17036040.
11. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313:1785-1787. 10.1126/science.1127592, 16990548.
12. Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen JJ, Zhao Y, Chao S, Cheong W, Ke Y, Al-Ahmadie H, Gerald WL, Brogi E, Benezra R. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res 2006, 66:10870-10877. 10.1158/0008-5472.CAN-06-2643, 17108123.
13. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401:670-677. 10.1038/44334, 10537105.
14. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK, Shahrara S, Campbell PL, Koch AE. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006, 54:765-778. 10.1002/art.21662, 1472704, 16508941.
15. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005, 52:3004-3014. 10.1002/art.21301, 16200580.
16. van der Voort R, van Lieshout AW, Toonen LW, Sloetjes AW, van den Berg WB, Figdor CG, Radstake TR, Adema GJ. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 2005, 52:1381-1391. 10.1002/art.21004, 15880344.
17. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS ONE 2008, 3:e2934. 10.1371/journal.pone.0002934, 2488395, 18698345.
18. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, Ortiz-Lopez A, Wu HJ, Mathis D, Benoist C. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007, 136:269-282. 10.1007/978-1-59745-402-5_20, 17983155.
19. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC. Endothelial progenitor cells' " homing" specificity to brain tumors. Gene Ther 2004, 11:811-818. 10.1038/sj.gt.3302151, 15057261.
20. Silverman MD, Haas CS, Rad AM, Arbab AS, Koch AE. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 2007, 56:1817-1826. 10.1002/art.22706, 17530710.
21. Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032. 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N, 11352233.
22. Ruth JH, Rottman JB, Katschke KJ, Qin S, Wu L, LaRosa G, Ponath P, Pope RM, Koch AE. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001, 44:2750-2760. 10.1002/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C, 11762935.
23. Everly DN, Mainou BA, Raab-Traub N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 2004, 78:13470-13478. 10.1128/JVI.78.24.13470-13478.2004, 533955, 15564458.
24. Marotte H, Ahmed S, Ruth JH, Koch AE. Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A. Arthritis Rheum 2010, 62:722-731. 10.1002/art.27269, 2855552, 20131228.
25. Folkman J, Haudenschild C. Angiogenesis by capillary endothelial cells in culture. Trans Ophthalmol Soc U K 1980, 100:346-353.
26. Masuda H, Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003, 58:390-398. 10.1016/S0008-6363(02)00785-X, 12757873.
27. Gao D, Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med 2009, 15:333-343. 10.1016/j.molmed.2009.06.006, 19665928.
28. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008, 105:6620-6625. 10.1073/pnas.0710516105, 2365563, 18443294.
29. Mellick AS, Plummer PN, Nolan DJ, Gao D, Bambino K, Hahn M, Catena R, Turner V, McDonnell K, Benezra R, Brink R, Swarbrick A, Mittal V. Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. Cancer Res 2010, 70:7273-7282. 10.1158/0008-5472.CAN-10-1142, 3058751, 20807818.
30. Jodon de Villeroche V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther 2010, 12:R27. 10.1186/ar2934, 2875661, 20158894.
31. Sakurai D, Yamaguchi A, Tsuchiya N, Yamamoto K, Tokunaga K. Expression of ID family genes in the synovia from patients with rheumatoid arthritis. Biochem Biophys Res Commun 2001, 284:436-442. 10.1006/bbrc.2001.4974, 11394898.
32. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002, 2:473-483. 10.1016/S1535-6108(02)00209-X, 12498716.
33. Ciarrocchi A, Jankovic V, Shaked Y, Nolan DJ, Mittal V, Kerbel RS, Nimer SD, Benezra R. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS ONE 2007, 2:e1338. 10.1371/journal.pone.0001338, 2129121, 18092003.
34. Hong SH, Lee JH, Lee JB, Ji J, Bhatia M. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J Cell Sci 2011, 124:1445-1452. 10.1242/jcs.077511, 21486943.
35. Szekanecz Z, Koch AE. Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol 2009, 51:1-7. 10.1016/j.vph.2009.02.002, 2917972, 19217946.
36. Ling MT, Kwok WK, Fung MK, Xianghong W, Wong YC. Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells. Carcinogenesis 2006, 27:205-215. 10.1093/carcin/bgi217, 16123120.
37. Neff AT, Lee JY, Wilusz J, Tian B, Wilusz CJ. Global analysis reveals multiple pathways for unique regulation of mRNA decay in induced pluripotent stem cells. Genome Res 2012, 22:1457-1467. 10.1101/gr.134312.111, 3409259, 22534399.
38. Ruth JH, Esnault S, Jarzembowski JA, Malter JS. Calcium ionophore upregulation of AUUUA-specific binding protein activity is contemporaneous with granulocyte macrophage colony-stimulating factor messenger RNA stabilization in AML14.3D10 cells. Am J Respir Cell Mol Biol 1999, 21:621-628. 10.1165/ajrcmb.21.5.3694, 10536121.
39. Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007, 56:1076-1086. 10.1002/art.22439, 17393416.
40. Isozaki T, Arbab AS, Haas CS, Amin MA, Arendt MD, Koch AE, Ruth JH. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: studies in mice with K/BxN serum-induced arthritis. Arthritis Rheum 2013, 65:1736-1746. 10.1002/art.37981, 23633118.